Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Operating Expenses (2016 - 2026)

Argenx Se's (ARGX) quarterly Operating Expenses came in at -$1.0 billion in Q2 2026, down 36.79% on a YoY basis from -$1.7 billion in Q2 2025, and down 14.04% quarter-over-quarter from -$919.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Operating Expenses (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Operating Expenses for 11 consecutive years, with -$1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses fell 36.79% year-over-year to -$1.0 billion; the trailing twelve-month figure through Jun 2026 stood at -$3.7 billion (down 39.73% YoY), and the FY2025 full-year result was -$3.2 billion, down 40.49% from the prior year.
  • Operating Expenses slipped to -$1.0 billion in Q2 2026 per ARGX's latest filing, from -$919.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at -$254.2 million in Q1 2022 and bottomed at -$1.0 billion in Q2 2026.
  • Historically, Operating Expenses has averaged -$571.9 million across 5 years, with a median of -$545.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Operating Expenses declined 12.08% in 2022, then sank 87.65% in 2023.
  • Over 5 years, Operating Expenses stood at -$296.5 million in 2022, then tumbled by 87.65% to -$556.5 million in 2023, then fell by 18.28% to -$658.2 million in 2024, then tumbled by 45.03% to -$954.5 million in 2025, then fell by 9.79% to -$1.0 billion in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$1.0 billion, -$919.0 million, and -$954.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 10.12 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 10.56 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -9.70 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 18.20 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 2.09 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn -1.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.05 Bn
Mar 31, 2026 -919.00 Mn
Dec 31, 2025 -954.54 Mn
Sep 30, 2025 -805.14 Mn
Jun 30, 2025 -766.13 Mn
Mar 31, 2025 -668.00 Mn
Dec 31, 2024 -658.18 Mn
Sep 30, 2024 -574.69 Mn
Jun 30, 2024 -534.89 Mn
Mar 31, 2024 -505.93 Mn
Dec 31, 2023 -556.46 Mn
Sep 30, 2023 -420.43 Mn
Jun 30, 2023 -383.13 Mn
Mar 31, 2023 -333.62 Mn
Dec 31, 2022 -296.55 Mn
Sep 30, 2022 -355.13 Mn
Jun 30, 2022 -259.73 Mn
Mar 31, 2022 -254.21 Mn
Dec 31, 2021 -264.60 Mn
Sep 30, 2021 -220.06 Mn
API Access

Argenx Se Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ARGX&period=max&api_key=YOUR_API_KEY